Literature DB >> 35090775

SEA 2022 Standards for Global Control of Cardiovascular Risk.

Jose Maria Mostaza1, Xavier Pintó2, Pedro Armario3, Luis Masana4, José T Real5, Pedro Valdivielso6, Teresa Arrobas-Velilla7, Ramón Baeza-Trinidad8, Pilar Calmarza9, Jesús Cebollada10, M Civera-Andrés11, J I Cuende Melero12, J L Díaz-Díaz13, J Fernández Pardo14, C Guijarro15, C Jericó3, M Laclaustra16, C Lahoz17, J López-Miranda18, S Martínez-Hervás5, O Muñiz-Grijalvo19, J A Páramo20, V Pascual21, J Pedro-Botet22, P Pérez-Martínez18, N Plana4, J Puzo23, M Á Sánchez Chaparro24, L Vila25.   

Abstract

One of the objectives of the Spanish Society of Arteriosclerosis is to contribute to better knowledge of vascular disease, its prevention and treatment. It is well known that cardiovascular diseases are the leading cause of death in our country and entail a high degree of disability and health care costs. Arteriosclerosis is a multifactorial disease and therefore its prevention requires a global approach that takes into account the different risk factors with which it is associated. Therefore, this document summarizes the current level of knowledge and includes recommendations and procedures to be followed in patients with established cardiovascular disease or at high vascular risk. Specifically, this document reviews the main symptoms and signs to be evaluated during the clinical visit, the laboratory and imaging procedures to be routinely requested or requested for those in special situations. It also includes vascular risk estimation, the diagnostic criteria of the different entities that are cardiovascular risk factors, and makes general and specific recommendations for the treatment of the different cardiovascular risk factors and their final objectives. Finally, the document includes aspects that are not usually referenced in the literature, such as the organization of a vascular risk consultation.
Copyright © 2021 The Authors. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Arterial hypertension; Atrial Fibrillation; Cardiovascular prevention; Diabetes; Dislipemia; Dyslipidaemia; Fibrilación auricular; Hipertensión arterial; Prevención cardiovascular; Smoking; Tabaquismo

Mesh:

Year:  2022        PMID: 35090775     DOI: 10.1016/j.arteri.2021.11.003

Source DB:  PubMed          Journal:  Clin Investig Arterioscler        ISSN: 0214-9168


  2 in total

1.  Implementation of a biochemical, clinical, and genetic screening programme for familial hypercholesterolemia in 26 centres in Spain: The ARIAN study.

Authors:  Teresa Arrobas Velilla; Ángel Brea; Pedro Valdivielso
Journal:  Front Genet       Date:  2022-08-29       Impact factor: 4.772

2.  Study of common hypertriglyceridaemia genetic variants and subclinical atherosclerosis in a group of women with SLE and a control group.

Authors:  Marta Fanlo-Maresma; Virginia Esteve-Luque; Xavier Pintó; Ariadna Padró-Miquel; Emili Corbella; Beatriz Candás-Estébanez
Journal:  Lupus Sci Med       Date:  2022-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.